Sugi Predict

Sugi Predict / Compounds / SCHEMBL1482696

SCHEMBL1482696

SCHEMBL1482696

C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](OC(C)=O)CCC(C)(C)[C@@H]3[C@H](O)[C@H](O)[C@@]2(C)O1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADCY1 Q08828 14/20 0.72
▸ MAPK1 P28482 5/20 0.72
▸ CYP3A4 P08684 4/20 0.72
▸ TSHR P16473 3/20 0.72
▸ NR1I2 O75469 2/20 0.72
▸ ADRA1A P35348 2/20 0.72
▸ KMT2A Q03164 2/20 0.72
▸ CYP2C19 P33261 2/20 0.72
▸ GMNN O75496 1/20 0.72
▸ BLM P54132 1/20 0.72
▸ PMP22 Q01453 1/20 0.72
▸ NPSR1 Q6W5P4 1/20 0.72
▸ CYP2D6 P10635 1/20 0.72
▸ NFKB1 P19838 1/20 0.72
▸ HIF1A Q16665 1/20 0.72
▸ CHRM2 P08172 1/20 0.72
▸ ABCB1 P08183 1/20 0.72
▸ HTR1A P08908 1/20 0.72
▸ ADRA2A P08913 1/20 0.72
▸ SLC2A1 P11166 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9870619 0.92 ADCY1 (0.85) ADCY1MAPK1CYP3A4TSHRNR1I2
SCHEMBL10513758 0.92 ADCY1 (0.85) ADCY1MAPK1CYP3A4TSHRNR1I2
SCHEMBL8526727 0.91 ADCY1 (0.63) ADCY1MAPK1CYP3A4TSHRNR1I2
SCHEMBL8653305 0.91 ADCY1 (0.63) ADCY1MAPK1CYP3A4TSHRNR1I2
SCHEMBL8500488 0.89 ADCY1 (0.61) ADCY1MAPK1CYP3A4TSHRNR1I2
SCHEMBL8501611 0.87 ADCY1 (0.58) ADCY1MAPK1CYP3A4TSHRNR1I2
Bicarbonate SCHEMBL10729136 0.86 ADCY1 (0.57) ADCY1MAPK1CYP3A4TSHRNR1I2
SCHEMBL10733447 0.85 ADCY1 (0.56) ADCY1MAPK1CYP3A4TSHRNR1I2
Bicarbonate SCHEMBL10729142 0.85 ADCY1 (0.57) ADCY1MAPK1CYP3A4TSHRNR1I2
SCHEMBL10920909 0.85 ADCY1 (0.77) ADCY1MAPK1CYP3A4TSHRNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110077292-A1 FORSKOLIN CARBONATES AND USES THEREOF BIOTEST LABORATORIES, LLC. (US) 2011-03-31 — — US disclosed
US-20100076070-A1 Forskolin Compositions and Methods For Administration BIOTEST LABORATORIES, LLC. (US) 2010-03-25 — — US disclosed
US-20060024341-A1 Microemulsion composition and related method BIOTEST LABORATORIES, LLC 2006-02-02 — — US disclosed
US-20060004090-A1 Forskolin compositions and methods for administration BIOTEST LABORATORIES, LLC 2006-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076070-A1 Forskolin Compositions and Methods For Administration ADCY9, ADCY7, ADCY6 ADCY1 5/4885MAPK1 2956/4885CYP3A4 246/4885
US-20110077292-A1 FORSKOLIN CARBONATES AND USES THEREOF ADCY9, ADCY1, ADCY7 ADCY1 2/4885MAPK1 1928/4885CYP3A4 2109/4885
US-20060024341-A1 Microemulsion composition and related method LIPA, SGMS1, SGMS2 ADCY1 3835/4885MAPK1 4707/4885CYP3A4 1827/4885
US-20060004090-A1 Forskolin compositions and methods for administration ADCY9, ADCY7, ADCY6 ADCY1 5/4885MAPK1 2956/4885CYP3A4 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.